Heron Therapeutics Inc vs Simon Property Group Inc — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Simon Property Group Inc trades at $219.28 (market cap $71.03B). The key difference: Simon Property Group Inc is far larger — about 1155.5× Heron Therapeutics Inc's market cap, and Simon Property Group Inc pays a 4.05% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | SPG | |
|---|---|---|
Market Cap | $61.47M | $71.03B |
Sector | Health | Real Estate |
52-Week High | $1.49 | $236.70 |
52-Week Low | $0.32 | $169.22 |
Enterprise Value | $168.21M | $99.48B |
Dividend Yield | — | 4.05% |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Simon Property Group is the second- largest real estate investment trust in the United States. Its portfolio includes an interest in 207 properties: 119 traditional malls, 69 premium outlets, 14 Mills centers (a combination of a traditional mall, outlet center, and big-box retailers), six lifestyle centers, and five other retail properties. Simon's portfolio averaged $693 in sales per square foot over the 12 months prior to the pandemic. The company also owns a 21% interest in Klepierre, a European retail company with investments in shopping centers in 16 countries, and joint venture interests in 33 premium outlets across 11 countries.
Read more on SPG →